- Host-pathogen interactions
- Malaria
- Parasitology
- +۷ مورد دیگر
Liliana Mancio Silva is a researcher at the Institut Pasteur in Paris, France, where she leads projects focused on malaria pathogenesis and drug discovery. She is the Principal Investigator of the PANDORA project, which aims to identify drugs effective against all stages of malaria using data from the COSIPOP cohort. Her research leverages advanced bioengineered human liver systems and single-cell technologies to study host-pathogen interactions, particularly in Plasmodium vivax and Plasmodium falciparum infections. Her research interests include host-pathogen interactions, metabolism in infectious disease, parasite dormancy (hypnozoites), single-cell analysis, and drug repurposing. She investigates how malaria parasites manipulate host hepatocyte metabolism and how circadian rhythms influence drug responses. Her work bridges molecular parasitology, systems biology, and translational medicine. The recent publications highlight a strong trend in single-cell and transcriptomic analysis of Plasmodium infection, the development of humanized liver models, and the exploration of host metabolic pathways as therapeutic targets. Her work spans from basic mechanisms of parasite biology to applied drug discovery. Scientific Awards: Liliana Mancio Silva advises several PhD students and postdoctoral researchers and is involved in collaborative drug discovery initiatives at the Institut Pasteur. She has no listed formal education in the provided text, but her publication record suggests a strong background in molecular parasitology and cell biology. She is actively involved in the development and application of bioengineered liver platforms (microlivers) for studying hepatotropic pathogens such as malaria parasites and hepatitis viruses.






